Crown Prince and Prime Minister Support Homeland
The article discusses the success story of treating "sickle cell disease" in Bahrain using the gene-editing technology "CRISPR." Bahrain has become the first regional country and the second globally to approve the use of this advanced treatment. The Bahraini young man, Amjad, who was suffering from the disease, was treated with unprecedented success outside the United States after undergoing multiple therapy sessions and bone marrow transplants utilizing this modern technology. This initiative has offered new hope to sickle cell patients, with treatment costs reaching approximately two million dinars per case. It also highlights the country's commitment to advancing healthcare and investing in human health. Moreover, the leadership’s follow-up and directives played a key role in transforming this case into a national medical achievement, reflecting the progress of Bahrain’s healthcare sector.
Notice: This Is an AI-Generated Summary
Comments (0)